Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies, ... Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies, and offers treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as well as diagnostics products. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Synbiotics, and Acarovac Plus. It also develops Grass MATA MPL, a subcutaneous allergen-specific immunotherapy candidate that aims to address the cause of symptoms of allergic rhinoconjunctivitis due to grass pollen; and VLP Peanut, a short-course peanut allergy vaccine. Allergy Therapeutics plc was founded in 1998 and is headquartered in Worthing, the United Kingdom. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1 | -11.4285714286 | 8.75 | 9.29 | 7.75 | 268727 | 8.16621652 | DE |
| 4 | -1.5 | -16.2162162162 | 9.25 | 10.25 | 7.75 | 297068 | 8.84599512 | DE |
| 12 | -2.25 | -22.5 | 10 | 11.425 | 7.75 | 248775 | 9.58992377 | DE |
| 26 | -2.5 | -24.3902439024 | 10.25 | 12.15 | 7.75 | 262154 | 10.4360948 | DE |
| 52 | 0.75 | 10.7142857143 | 7 | 12.15 | 6.6 | 306815 | 9.25455251 | DE |
| 156 | 1.5 | 24 | 6.25 | 12.15 | 0.85 | 623825 | 4.1434778 | DE |
| 260 | -17.75 | -69.6078431373 | 25.5 | 40 | 0.85 | 434587 | 7.35586047 | DE |
FlashySage44
4分前
FlashySage44
23分前
jay_tee
40分前
doogdilinger
48分前
joe_techi
59分前
xoom
1時間前
gregcod
1時間前
rodeoup
2時間前
satter
3時間前
eagle8
3時間前
t1215s
3時間前
europa7
4時間前
barnstormer
4時間前
europa7
4時間前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。